• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发现并利用高效生物标志物用于阿尔茨海默病客观疾病状态评估。

Discovery and use of efficient biomarkers for objective disease state assessment in Alzheimer's disease.

作者信息

van Gils Mark, Koikkalainen Juha, Mattila Jussi, Herukka Sannakaisa, Lotjonen Jyrki, Soininen Hilkka

机构信息

VTT Technical Research Centre of Finland, Tampere, Finland.

出版信息

Annu Int Conf IEEE Eng Med Biol Soc. 2010;2010:2886-9. doi: 10.1109/IEMBS.2010.5626311.

DOI:10.1109/IEMBS.2010.5626311
PMID:21095977
Abstract

Objective and early detection of Alzheimer's disease (AD) is a demanding problem requiring consideration of manymodal observations. Potentially, many features could be used to discern between people without AD and those at different stages of the disease. Such features include results from cognitive and memory tests, imaging (MRI, PET) results, cerebral spine fluid data, blood markers etc. However, in order to define an efficient and limited set of features that can be employed in classifiers requires mining of data from many patient cases. In this study we used two databases, ADNI and Kuopio LMCI, to investigate the relative importance of features and their combinations. Optimal feature combinations are to be used in a Clinical Decision Support System that is to be used in clinical AD diagnosis practice.

摘要

阿尔茨海默病(AD)的客观早期检测是一个具有挑战性的问题,需要考虑多种模态的观察结果。潜在地,许多特征可用于区分未患AD的人和处于疾病不同阶段的人。这些特征包括认知和记忆测试结果、成像(MRI、PET)结果、脑脊液数据、血液标志物等。然而,为了定义一组可用于分类器的高效且有限的特征集,需要从许多患者病例中挖掘数据。在本研究中我们使用了两个数据库,即ADNI和库奥皮奥轻度认知障碍倡议(Kuopio LMCI),来研究特征及其组合的相对重要性。最佳特征组合将用于一个临床决策支持系统,该系统将用于临床AD诊断实践。

相似文献

1
Discovery and use of efficient biomarkers for objective disease state assessment in Alzheimer's disease.发现并利用高效生物标志物用于阿尔茨海默病客观疾病状态评估。
Annu Int Conf IEEE Eng Med Biol Soc. 2010;2010:2886-9. doi: 10.1109/IEMBS.2010.5626311.
2
Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.阿尔茨海默病成像生物标志物的比较:使用[18F]氟比他哌正电子发射断层扫描进行淀粉样蛋白成像以及对内嗅皮质萎缩进行基于磁共振成像体素的分析。
Int J Geriatr Psychiatry. 2015 May;30(5):505-13. doi: 10.1002/gps.4173. Epub 2014 Jul 7.
3
A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic.在记忆门诊中比较 MRI、CBF-SPECT、FDG-PET 和脑脊液生物标志物对阿尔茨海默病的诊断灵敏度。
Dement Geriatr Cogn Disord. 2010;30(4):285-92. doi: 10.1159/000320265. Epub 2010 Sep 22.
4
Feasibility and acceptance of simultaneous amyloid PET/MRI.同步淀粉样蛋白PET/MRI的可行性与可接受性。
Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2236-2243. doi: 10.1007/s00259-016-3462-x. Epub 2016 Jul 19.
5
Reproducible evaluation of classification methods in Alzheimer's disease: Framework and application to MRI and PET data.阿尔茨海默病分类方法的可再现性评估:框架及在 MRI 和 PET 数据中的应用。
Neuroimage. 2018 Dec;183:504-521. doi: 10.1016/j.neuroimage.2018.08.042. Epub 2018 Aug 18.
6
Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.比较神经影像学方法在预测轻度认知障碍向阿尔茨海默病痴呆转化中的应用。
Neurobiol Aging. 2014 Jan;35(1):143-51. doi: 10.1016/j.neurobiolaging.2013.06.018. Epub 2013 Aug 15.
7
[Biomarkers for early diagnosis of Alzheimer's disease].
Ugeskr Laeger. 2015 Jun 8;177(24).
8
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.阿尔茨海默病中脑脊液淀粉样蛋白-β与氟代硼吡咯(florbetapir)成像的独立信息
Brain. 2015 Mar;138(Pt 3):772-83. doi: 10.1093/brain/awu367. Epub 2014 Dec 24.
9
Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression.多参数PET在预测阿尔茨海默病进展中的潜在临床价值
PLoS One. 2016 May 16;11(5):e0154406. doi: 10.1371/journal.pone.0154406. eCollection 2016.
10
Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.成像模态、脑图谱和特征选择对阿尔茨海默病预测的影响。
J Neurosci Methods. 2015 Dec 30;256:168-83. doi: 10.1016/j.jneumeth.2015.08.020. Epub 2015 Aug 28.

引用本文的文献

1
Mild Cognitive Impairment: Data-Driven Prediction, Risk Factors, and Workup.轻度认知障碍:数据驱动的预测、风险因素及检查
AMIA Jt Summits Transl Sci Proc. 2023 Jun 16;2023:167-175. eCollection 2023.
2
Deep Learning Prediction of Mild Cognitive Impairment using Electronic Health Records.利用电子健康记录进行轻度认知障碍的深度学习预测
Proceedings (IEEE Int Conf Bioinformatics Biomed). 2019 Nov;2019:799-806. doi: 10.1109/bibm47256.2019.8982955. Epub 2020 Feb 6.
3
Advancing Alzheimer's research: A review of big data promises.推进阿尔茨海默病研究:大数据前景综述
Int J Med Inform. 2017 Oct;106:48-56. doi: 10.1016/j.ijmedinf.2017.07.002. Epub 2017 Jul 24.
4
A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers.一项对纵向研究阿尔茨海默病生物标志物的系统评价。
J Alzheimers Dis. 2017;59(4):1359-1379. doi: 10.3233/JAD-170261.
5
2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.阿尔茨海默病神经影像学计划2014年更新:自启动以来发表论文综述
Alzheimers Dement. 2015 Jun;11(6):e1-120. doi: 10.1016/j.jalz.2014.11.001.
6
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.阿尔茨海默病神经影像学倡议:成立以来发表论文的综述。
Alzheimers Dement. 2013 Sep;9(5):e111-94. doi: 10.1016/j.jalz.2013.05.1769. Epub 2013 Aug 7.
7
A two-study comparison of clinical and MRI markers of transition from mild cognitive impairment to Alzheimer's disease.一项关于从轻度认知障碍转变为阿尔茨海默病的临床和磁共振成像标志物的两项研究比较。
Int J Alzheimers Dis. 2012;2012:483469. doi: 10.1155/2012/483469. Epub 2012 Feb 1.
8
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.阿尔茨海默病神经影像学倡议:成立以来发表论文的回顾。
Alzheimers Dement. 2012 Feb;8(1 Suppl):S1-68. doi: 10.1016/j.jalz.2011.09.172. Epub 2011 Nov 2.
9
Brain functional network in Alzheimer's disease: diagnostic markers for diagnosis and monitoring.阿尔茨海默病中的脑功能网络:用于诊断和监测的诊断标志物。
Int J Alzheimers Dis. 2011;2011:481903. doi: 10.4061/2011/481903. Epub 2011 May 18.